According to biotech leader Leen Kawas, the integration of AI with biological data marks a critical juncture that presents both unprecedented opportunities and complex ethical challenges.

after resigning in the wake of a company investigation concluding she had altered images… Read More Leen Kawas has formally resigned as CEO and president of Athira Pharma and is stepping off the ...

The misconduct involved manipulated scientific images by the company’s former CEO, Leen Kawas, which were used in grant ...

Leen Kawas is the co-founder and managing general partner at Propel Bio Partners, where she is spearheading a biotech-focused fund aimed at advancing life science innovations. Drawing on her ...

Harding approached Jordan-born Leen Kawas, then a postdoctoral researcher and now M3’s president and CEO, with the suggestion that she work with him to commercialize the team’s ...

Scientist and pharmaceutical researcher Andrew P. Mallon—who first reported to NIH and others in 2016 his suspicions that then-Athira Pharma CEO Leen Kawas falsified data in published papers ...

Harding approached Jordan-born Leen Kawas, then a postdoctoral researcher and now Athira’s president and CEO, with the suggestion that she work with him to commercialize the team’s neurodegen ...